about
Ultrasonic-activated micellar drug delivery for cancer treatment.Quantum dot loaded immunomicelles for tumor imaging.Amphiphilic nanoparticles repress macrophage atherogenesis: novel core/shell designs for scavenger receptor targeting and down-regulation.The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.Self-assembly of phospholipid-PEG coating on nanoparticles through dual solvent exchange.Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosisConstruction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity.Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacyChemical modification and formulation approaches to elevated drug transport across cell membranes.Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug deliveryUse of degradable and nondegradable nanomaterials for controlled release.Techniques for efficient entrapment of pharmaceuticals in biodegradable solid micro/nanoparticles.Receptor-targeted nanocarriers for therapeutic delivery to cancer.Immunoconjugates and long circulating systems: origins, current state of the art and future directionsSelf-assembled liposomal nanoparticles in photodynamic therapy.PEG-lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication.Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease.Improving "lab-on-a-chip" techniques using biomedical nanotechnology: a review.Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS.Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.Anticancer efficacy and toxicokinetics of a novel paclitaxel-clofazimine nanoparticulate co-formulation.Micellar formulations of pro-apoptotic DM-PIT-1 analogs and TRAIL in vitro and in vivo.Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery.Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats.PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.Caleosin-assembled oil bodies as a potential delivery nanocarrier.Nanoparticle encapsulated silver carbene complexes and their antimicrobial and anticancer properties: a perspective.Palmitoyl ascorbate-loaded polymeric micelles: cancer cell targeting and cytotoxicity.Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5.Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents."SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy.Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.An update on nanoparticle-based contrast agents in medical imaging.Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin.Synthesis and Purification of Homogeneous Lipid-Based Peptide Nanocarriers by Overcoming Phospholipid Ester Hydrolysis
P2860
Q30490995-BB431919-83D5-43CD-AB8F-7625A18E92EAQ33721349-F1214E7B-50AB-4FF2-B642-CDCD4C513C5CQ34089117-BD7D90D5-B452-4BED-81D3-3F3F2D85EFD7Q34615075-6D6C39F7-2FD6-44DE-98BB-7DE661E7056DQ35214397-F833DDFA-9E71-440C-B186-1805E53F5D32Q35710262-E10E4188-AA38-4FFF-977D-A439DE92CE4CQ35822282-1B349759-AF8E-4301-9DD7-905ED2993A2CQ36390180-BAD4ABD8-E1D1-4324-9A53-CD8FB7CE720DQ36527751-7D5213E5-283E-43E9-B8F3-23E62085D5CAQ36583732-42994584-E476-4656-8D2E-95CB8C855B73Q36653608-1C0470F4-D69D-49E7-948A-8CC8D9DAF592Q36917951-C871C3A1-4AB9-4082-9B83-B284603D69BCQ37709421-CE083FEB-43A8-491D-804E-D0B818F1FB46Q37804383-AF2F311A-4F1A-4A11-B589-E3A87DF9982DQ38042256-A26811D7-9D14-4832-B74A-D39B5B14F1B2Q38172124-E335FFD0-1B2E-453C-A510-11B4B03895BDQ38303124-411F3536-D60B-4AA4-997A-46CB7F2508A6Q38682342-33D3899F-A193-46C2-9E29-8221B2BBB5F3Q38694046-FBC2E184-326D-455A-900C-4A8FC70632A3Q38755306-BDDBBF48-F17F-4610-9AAA-3612E02A0017Q38788181-EFF617B7-4D6F-40CC-8228-2EE72F2B4A47Q38896952-B5B91659-2857-4CEC-9719-DF0D8B25A197Q39180790-F71E9C0D-87B5-4502-99BE-3801B5381AF6Q39237999-1059AE3A-B5F2-445F-A07E-FD5D85538BD6Q39266934-9F6C9292-3736-48A0-8292-6302B1DB9338Q39337524-7F641B12-7EB5-454F-A852-D3AADB8BABD7Q39364129-58552C92-AEA9-4293-8AA5-B6C105BAF0B4Q39435599-17CB386A-6A29-43B8-8003-C31BC7A8A0DAQ39462821-63058011-56CC-4943-9D20-E7AC335F55E7Q39664565-EB76CD5E-5CD7-409F-941F-09BFE71A696EQ39967885-27831F4E-6B5A-46C5-B837-0B21F1666470Q41327051-309DDC93-23CF-4BC8-8BFF-D932E42E555EQ41890311-E5BC96E2-F547-4A7A-9194-607D9A1FC877Q42207993-71DB87A6-0B71-46C2-BF90-5D226F4947F7Q42544966-F560B251-C8BB-4F27-A778-9B9A794B61A1Q43564347-F61B3917-53EE-4C97-B864-3DC1035C5AE3Q44933611-10E2FFD9-C258-4C13-85B8-69F42E9AB325Q48654705-FDD9B5C2-DDD6-4732-B078-C5FC32C195CCQ50467668-E127FCCD-FF46-4473-A9E1-B75DEAFE3B29Q58580939-50F99B4A-26CA-4F12-9569-4AE122A8B7C3
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Lipid-core micelles for targeted drug delivery.
@ast
Lipid-core micelles for targeted drug delivery.
@en
type
label
Lipid-core micelles for targeted drug delivery.
@ast
Lipid-core micelles for targeted drug delivery.
@en
prefLabel
Lipid-core micelles for targeted drug delivery.
@ast
Lipid-core micelles for targeted drug delivery.
@en
P1476
Lipid-core micelles for targeted drug delivery.
@en
P2093
Vladimir P Torchilin
P304
P356
10.2174/156720105774370221
P577
2005-10-01T00:00:00Z